{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:28:47Z","timestamp":1740144527502,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0567-7","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:42:43Z","timestamp":1484959363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union"],"prefix":"10.1186","volume":"12","author":[{"given":"Benedetta","family":"Polsinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stelios","family":"Tsigkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Naumann-Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Segundo","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-0955","authenticated-orcid":false,"given":"Bruno","family":"Sepodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,21]]},"reference":[{"key":"567_CR1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(14)70282-7","volume":"15","author":"M Sant","year":"2014","unstructured":"Sant M, E.-5. W. Group. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 2014;15:931\u201342.","journal-title":"Lancet Oncol"},{"key":"567_CR2","unstructured":"Opinions for Rare disease (orphan) designations. Eur Med Agency, [Online]. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/landing\/orphan_search.jsp&mid=WC0b01ac058001d12b . Accessed 21 Sept 2016"},{"key":"567_CR3","unstructured":"Survival of cancer patients in Europe. Eurocare, [Online]. Available: http:\/\/www.eurocare.it\/ . Accessed 25 Aug 2016"},{"key":"567_CR4","unstructured":"Statistics for haematological malignancies. Haematol Malig Res Netw, [Online]. Available: http:\/\/www.hmrn.org\/statistics . Accessed 25 Aug 2016"},{"key":"567_CR5","unstructured":"COMP: Agendas, minutes and meeting reports. Eur Med Agency, [Online]. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/document_listing\/document_listing_000201.jsp&mid=WC0b01ac0580028e78#section2 . Accessed 21 Sept 2016"},{"key":"567_CR6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122\u20138.","journal-title":"Leukemia"},{"key":"567_CR7","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516\u201320.","journal-title":"Blood"},{"key":"567_CR8","unstructured":"Cancer Research UK - statistics by cancer type. Cancer Res UK, [Online]. Available: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type . Accessed 21 Sept 2016"},{"issue":"9","key":"567_CR9","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","volume":"34","author":"H Bower","year":"2016","unstructured":"Bower H. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016;34(9):2851\u20137.","journal-title":"J Clin Oncol"},{"key":"567_CR10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","volume":"45","author":"W. Group","year":"2009","unstructured":"W. Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary. Eur J Cancer. 2009;45:931\u201391.","journal-title":"Eur J Cancer"},{"key":"567_CR11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY. Patterns of survival in multiple myeloma: a population-based study of patients. J Clin Oncol. 2007;25:1993\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:47:07Z","timestamp":1498366027000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0567-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0567-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2017,1,21]]},"article-number":"17"}}